Mucus Relief

NDC 76162-057 · TOPCO ASSOCIATES LLC

Generic nameDextromethorphan HBr, Guaifenesin, Phenylephrine HCl

Dosage formSOLUTION

RouteORAL

Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

Strength5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL

Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

76162-057-88 — 1 BOTTLE, PLASTIC in 1 CARTON (76162-057-88) / 201 mL in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

76095-012 — Guaifensin, Dextromethorphan, 76117-001 — CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, 76162-000 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 76162-004 — Guaifenesin 400mg, 76162-008 — Mucus Relief DM, 76162-026 — Nite Time Cold and Flu Relief, 76162-031 — Guaifenesin, 76162-032 — GUAIFENESIN AND DEXTROMETHORPHAN HBR, 76162-040 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 76162-050 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 76162-065 — Daytime Cold and Flu Relief, 76162-099 — brompheniramine maleate, dextromethorphan hydrobromide, 76162-123 — guaifenesin, 76162-198 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, 76162-202 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 76162-294 — Dextromethorphan HBr, Guaifensin, 76162-409 — guaifenesin, 76162-483 — acetaminophen, dextromethorphan hydrobromide, 76162-500 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 76162-523 — Guaifenesin, +3082 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels